Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,642
datasets available to search
ShareScore release 0.9.0
Dataset results
2,642 results for “blindness”
A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene
ClinicalTrials.gov study NCT07185347. IPD Sharing: YES. Countries: 1. Publications: 0.
A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
ClinicalTrials.gov study NCT00394901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Influence of Combining the Pulmonary Recruitment Maneuver with Active Gas Aspiration on Post-laparoscopic Shoulder Pain in Patients Having a Gynecologic Laparoscopy, Randomized Double Blinded Clin
ClinicalTrials.gov study NCT06753292. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®
ClinicalTrials.gov study NCT03962296. IPD Sharing: NO. Countries: 0. Publications: 1.
A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)
ClinicalTrials.gov study NCT03452488. IPD Sharing: NO. Countries: 2. Publications: 0.
Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects.
ClinicalTrials.gov study NCT02616770. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT01280695. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma
ClinicalTrials.gov study NCT02249052. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
ClinicalTrials.gov study NCT02493712. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
ClinicalTrials.gov study NCT04631016. IPD Sharing: YES. Countries: 15. Publications: 0.
The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial
ClinicalTrials.gov study NCT02783846. IPD Sharing: NO. Countries: 0. Publications: 1.
Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours
ClinicalTrials.gov study NCT02021461. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-li
ClinicalTrials.gov study NCT02290340. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Subacromial Ultrasound-guided or Systemic Steroid Injection for Rotator Cuff Disease, a Randomized Double Blinded Study
ClinicalTrials.gov study NCT00640575. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT02852967. IPD Sharing: NO. Countries: 1. Publications: 0.
Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00571519. IPD Sharing: NO. Countries: 1. Publications: 0.
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov study NCT01721330. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study（TOPS-CSVD）
ClinicalTrials.gov study NCT06061692. IPD Sharing: NO. Countries: 0. Publications: 1.
Stimulation of Gastric Slow Waves With Acupuncture at St36 and Pe6 - a Randomized Single-blind Controlled Trial
ClinicalTrials.gov study NCT00636012. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II/III Randomized Double-Blind Multicenter Study Comparing UC-MSC-Derived Secretome and Sodium Hyaluronate in Patients With Knee Osteoarthritis
ClinicalTrials.gov study NCT07337863. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.